• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Modifications of endocrine-metabolic abnormalities of uremia by continuous ambulatory peritoneal dialysis.

作者信息

Maher J F

机构信息

Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Md.

出版信息

Am J Nephrol. 1990;10(1):1-9. doi: 10.1159/000168047.

DOI:10.1159/000168047
PMID:2188504
Abstract

The endocrine-metabolic disturbances of renal failure have numerous underlying mechanisms. These include abnormal secretion, transport and target cell binding and impaired synthesis or elimination by the diseased kidney. Neither hemodialysis nor CAPD removes large quantities of retained hormones. By correcting certain metabolic, fluid and electrolyte abnormalities, however, dialysis may improve some endocrine disturbances. Other factors such as malnutrition, glucose loading, protein loss, trace metal accumulation and drug ingestion may influence the endocrine-metabolic aspects of renal failure treated by dialysis. Hormonal stimulation and action can be adversely affected by hyperendorphinism due to retained opioids which may be removed by dialysis [88]. Possibly due to the more permeable membrane or because of continuous therapy, peritoneal dialysis seems to have a more salutary effect on hormonal regulation of salt and water balance, of erythrocyte mass and of female reproductive function than hemodialysis does.

摘要

相似文献

1
Modifications of endocrine-metabolic abnormalities of uremia by continuous ambulatory peritoneal dialysis.
Am J Nephrol. 1990;10(1):1-9. doi: 10.1159/000168047.
2
Endocrine abnormalities in patients treated by continuous ambulatory peritoneal dialysis.接受持续性非卧床腹膜透析治疗患者的内分泌异常
Blood Purif. 1990;8(2):69-75. doi: 10.1159/000169927.
3
Peritoneal dialysis improves uremic endocrine disorders.腹膜透析可改善尿毒症内分泌紊乱。
Contrib Nephrol. 1990;84:45-51. doi: 10.1159/000418991.
4
[Metabolic and hormonal disorders in patients treated by peritoneal dialysis].[接受腹膜透析治疗患者的代谢和激素紊乱]
Przegl Lek. 1987;44(4):383-5.
5
[Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].[持续性非卧床腹膜透析或维持性血液透析的慢性肾衰竭患者多发性神经病变严重程度的评估]
Przegl Lek. 2007;64(6):423-30.
6
Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis.
Miner Electrolyte Metab. 1983 Mar-Apr;9(2):82-6.
7
Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.持续非卧床腹膜透析患者血浆脂蛋白(a)升高与蛋白质和葡萄糖的腹膜转运有关。
Nephron. 1996;72(2):135-44. doi: 10.1159/000188831.
8
[Continuous ambulatory peritoneal dialysis: determination of treatment location].[持续性非卧床腹膜透析:治疗地点的确定]
Dtsch Med Wochenschr. 1990 Dec 21;115(51-52):1975-9.
9
Baclofen neurotoxicity in uremic patients: is continuous ambulatory peritoneal dialysis less effective than intermittent hemodialysis?尿毒症患者的巴氯芬神经毒性:持续性非卧床腹膜透析是否比间歇性血液透析效果差?
Ren Fail. 2003 Mar;25(2):297-305. doi: 10.1081/jdi-120018730.
10
[Indications for hemo- and peritoneal dialysis].
Munch Med Wochenschr. 1966 Aug 5;108(31):1547-52.